Multiple myeloma patients with COVID-19 have high rates of hospitalization, ICU admission, and death, according to researchers.

Survey results suggest that cancer patients want financial toxicity screening to occur early, but screening preferences and practices vary.

(HealthDay News) — A wearable device may improve physical activity, physical function, dyspnea, and pain after lung cancer surgery, according to a study published in JAMA Network Open.

Researchers sought to determine the effect of antibiotics on the risk of colorectal cancer recurrence after surgery.

Trimodal therapy may be an effective alternative to radical cystectomy for recurrent, high-grade T1 bladder cancer, according to a study published in the Journal of Clinical Oncology.

Adding PD-(L)1 inhibitors to chemotherapy improved outcomes, but PD-(L)1 inhibitors alone were no more effective than chemotherapy alone in patients with gastric, gastroesophageal junction, and ...

Americans have the worst health care among the world’s wealthy nations, according to a report from health care think-tank The Commonwealth Fund. The report showed that people in the United States die ...

Treatment with ¹⁷⁷Lu-PSMA-617 appears more effective than changing ARPIs for patients with mCRPC whose disease progressed on a prior ARPI.

(HealthDay News) — Axatilimab produces responses in patients with recurrent or refractory graft-vs-host disease (GVHD), according to a study published in The New England Journal of Medicine.

A large study suggests that pediatric cancer patients are more likely to die in the hospital than at home. The data showed that 52% of patients died in the hospital, and 40% died at home. These ...

SBRT and hypofractionated CRT produced similar outcomes in patients with inoperable stage I NSCLC in a phase 3 trial.

The FDA has approved Sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and dexamethasone for transplant-ineligible, newly diagnosed multiple myeloma.